Terns Pharmaceuticals Inc (TERN)

41.45 +0.00%

Terns Pharmaceuticals Inc (TERN) is currently trading at $41.45. This represents a gain of 0% from the previous session. With a market capitalization of $4.40B, TERN is a key component of the Health Care sector. Investors looking to trade TERN should compare margin rates and options platforms to optimize their portfolio management.

Broker Promotion
Claim Your $300 Cash Bonus → T&Cs Apply. Trade TERN commission-free.
Trading Platform Comparison
Moomoo
  • Min Deposit: $0
  • Commissions: $0
  • Fractional Shares: ✅
  • Options: ✅
  • Notes: Good for small traders
IBKR
  • Min Deposit: $0
  • Commissions: $0–$0.005/share
  • Fractional Shares: ✅
  • Options: ✅
  • Notes: Professional-level tools
Ameritrade
  • Min Deposit: $0
  • Commissions: $0
  • Fractional Shares: ✅
  • Options: ✅
  • Notes: Strong research tools
Webull
  • Min Deposit: $0
  • Commissions: $0
  • Fractional Shares: ✅
  • Options: ✅
  • Notes: Easy mobile app
AI Market Sentiment

As of today, Terns Pharmaceuticals Inc (TERN) shows a bullish trend. Analysts are watching the 0.00 level closely.

Fundamentals
Mkt Cap4.40B
P/E Ratio0.0000
Volume9
Others Watching (By Market Cap)
BAX
Baxter Internat $20.63
+0.00% EHC
Encompass Healt $104.84
+0.03% MDGL
Madrigal Pharma $440.00
+0.00% DVA
Davita Inc $150.91
+0.00% HSIC
Henry Schein In $83.35
+0.00%
60-Day Technical Chart
Advanced Charting

Need more indicators for TERN? Use the world's #1 platform.

Open TERN on TradingView →
Charting Platforms
TradingView

Advanced charts & indicators, web & mobile

StockCharts

Technical analysis charts with overlays & indicators

BarCharts

Market data, charts, and technical signals

Finviz

Visual stock charts & heatmaps

Yahoo Finance Charts

Basic interactive charts with indicators

Side-by-Side: Stocks Near $41
Metric TERN
+0.00% 		PLAB
+0.00% 		SHOO
+0.00% 		CNC
+0.00%
Price $41.45 $37.99 $37.36 $42.37
Mkt Cap $4.40B $2.24B $2.71B $20.84B
- View → View → View →
Latest Headlines
Commit To Buy Terns Pharmaceuticals At $30, Earn 34% Using Options Nasdaq • Feb 23, 2026 Terns Pharmaceuticals (TERN) Climbs 53% on Stellar Leukemia Treatment Trial Yahoo Finance • Dec 14, 2025 Fund Update: New $76.5M $TERN stock position opened by AMERIPRISE FINANCIAL INC Quiver Quantitative • Feb 17, 2026 Terns drug shows potential to challenge Novartis’ blockbuster leukemia treatment BioPharma Dive • Dec 8, 2025 Terns Pharmaceuticals (Nasdaq: TERN) starts $400M stock offering with $60M option Stock Titan • Dec 9, 2025
● Gemini Agentic AI Analyst Insight for TERN
Market Education
View All Articles →
External Research